Totally Robotic radical cystectomy with intracorporeal ileal conduit: initial experience
Total intra-corporeal robot-assisted radical cystectomy (RARC) with total intracorporeal ileal conduit is relatively new in the treatment of bladder cancer.
Materials and Methods
This is a consecutive case series of 6 patients, who underwent total RARC, pelvic lymphadenectomy and creation of an intra-corporeal ileal conduit. Surgical technique is described and perioperative variables, pathologic data, and complication rates are reported.
The mean patient age was 71.6 and the mean body mass index was 28.01 kg/m(2). The mean operative time, estimated blood loss, time to full diet and length of stay were 360.8 minutes , 250 min , 4 days (range: 3-6) and 8 days (range: 6-9), respectively. Pathological nodal status were positive in two patient. No peri-operative complication were reported. Only one patient with pT4aN2 pathological stage reported rectal pain 1 month after surgery.
The limitation of our study is its small sample size. The follow-up is short; however, the outcomes are encouraging expecially in the learning curve phase.
In our initial experience, RARC with total intracorporeal ileal conduit is safe. We expect that with experience the expense of robotic surgery can be compensated with early ambulation and shorter stay.Argomenti: cancro della vescica o alte vie urinarie